These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8171705)

  • 1. Studies of cyclosporine-associated arteriolopathy in renal transplantation: does the long-term outcome of renal allografts depend on chronic cyclosporine nephrotoxicity?
    Takeda A; Morozumi K; Yoshida A; Uchida K; Tominaga Y; Fujinami T; Yokoyama I; Takagi H
    Transplant Proc; 1994 Apr; 26(2):925-8. PubMed ID: 8171705
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts.
    Morozumi K; Thiel G; Gudat F; Mihatsch MJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):537-9. PubMed ID: 8438404
    [No Abstract]   [Full Text] [Related]  

  • 3. Is a late graft biopsy at 3 years after transplantation effective for improving the long-term outcome of renal allografts using cyclosporine?
    Morozumi K; Takeda A; Uchida K; Oda A; Oikawa T; Sugito K; Kodera K; Fujinami T; Tominaga Y; Yoshida A
    Transplant Proc; 1994 Apr; 26(2):945-8. PubMed ID: 8171713
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of cyclosporine-associated arteriolopathy in renal transplant biopsies from 1981 to 1992.
    Strøm EH; Thiel G; Mihatsch MJ
    Transplant Proc; 1994 Oct; 26(5):2585-7. PubMed ID: 7940802
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts.
    Morozumi K; Thiel G; Albert FW; Banfi G; Gudat F; Mihatsch MJ
    Clin Nephrol; 1992 Jul; 38(1):1-8. PubMed ID: 1499163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathology of renal allograft].
    Morozumi K; Kodera K; Takeda A
    Rinsho Byori; 1991 Jul; Suppl 90():82-101. PubMed ID: 1920858
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?
    Morozumi K; Takeda A; Uchida K; Mihatsch MJ
    Transplant Proc; 2004 Mar; 36(2 Suppl):251S-256S. PubMed ID: 15041348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria after renal allograft: assessment based on severity and causes.
    Jeong HJ; Kim YS; Oh CK; Park K; Choi IJ
    Transplant Proc; 1994 Aug; 26(4):2132-3. PubMed ID: 8066695
    [No Abstract]   [Full Text] [Related]  

  • 9. Risks and benefits of graft biopsy in renal transplantation under cyclosporin-A.
    Kiss D; Landmann J; Mihatsch M; Huser B; Brunner FP; Thiel G
    Clin Nephrol; 1992 Sep; 38(3):132-4. PubMed ID: 1395164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe cyclosporine arteriolopathy with focal segmental glomerulosclerosis is not a fatal finding in chronic renal allograft failure after year 5 of transplantation using cyclosporine.
    Takeda A; Morozumi K; Koyama K; Yoshida A; Uchida K; Tominaga Y; Haba T; Oikawa T; Usami T; Sugito K; Takeuchi O; Fujinami T; Yokoyama I; Takagi H
    Transplant Proc; 1997; 29(1-2):96-9. PubMed ID: 9123169
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteinuria in renal transplant recipients: incidence, cause, and prognostic importance.
    Kim HC; Park SB; Lee SH; Park KK; Park CH; Cho WH
    Transplant Proc; 1994 Aug; 26(4):2134-5. PubMed ID: 8066696
    [No Abstract]   [Full Text] [Related]  

  • 12. FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up.
    Offner G; Burdelski M; Hoyer PF; Winkler M; Brodehl J
    Transplant Proc; 1991 Dec; 23(6):3082-4. PubMed ID: 1721366
    [No Abstract]   [Full Text] [Related]  

  • 13. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
    Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression.
    Sugito K; Morozumi K; Oikawa T
    Transplant Proc; 1996 Jun; 28(3):1335-7. PubMed ID: 8658683
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal transplant morphology after long-term therapy with cyclosporine.
    Mihatsch MJ; Morozumi K; Strøm EH; Ryffel B; Gudat F; Thiel G
    Transplant Proc; 1995 Feb; 27(1):39-42. PubMed ID: 7879032
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy.
    Mihatsch MJ; Ryffel B; Gudat F
    Transplant Proc; 1993 Apr; 25(2):2031-7. PubMed ID: 8470264
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrastructural study of cyclosporine-associated arteriolopathy in renal allografts.
    Yamaguchi Y; Teraoka S; Yagisawa T; Takahashi K; Toma H; Ota K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1517-22. PubMed ID: 2652489
    [No Abstract]   [Full Text] [Related]  

  • 18. Balancing cyclosporine A nephrotoxicity and rejection late after adult liver transplantation.
    Paul A; Levy GA; Greig PD
    Transplant Proc; 1993 Aug; 25(4):2664-5. PubMed ID: 8356714
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of subclinical rejection on renal allograft histology and function at 6 months.
    Rush D; Jeffery J; Trpkov K; Solez K; Gough J
    Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic rejection in 500 kidney transplant patients treated with cyclosporine: incidence and risk factors.
    Pallardó LM; Sánchez J; Puig N; Sánchez P; Beneyto I; Crespo J; Ros F; Rochera A
    Transplant Proc; 1995 Aug; 27(4):2215-6. PubMed ID: 7652778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.